Journals
International Journal of Molecular Medicine
International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Molecular Medicine Reports
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Biomedical Reports
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
Molecular and Clinical Oncology
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
World Academy of Sciences Journal
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
International Journal of Functional Nutrition
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
International Journal of Epigenetics
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
Medicine International
An International Open Access Journal Devoted to General Medicine.
Search Results
81252 Results were found
Open Access
Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia
Joaquín Martínez-López, Pau Montesinos, Nieves López-Muñoz, Rosa Ayala, Pilar Martínez-Sánchez, Julian Gorrochategui, José Luis Rojas-Rudilla, Daniel Primo, Juan-Miguel Bergua-Burgues, María Calbacho, Evelyn Acuña-Cruz, José Antonio Pérez-Simón, Adolfo De La Fuente, Jaime Pérez De Oteyza, Rebeca Rodriguez-Veiga, José Sánchez Pina, Blanca Boluda, Isabel Cano, María Liz Paciello Coronel, Juan Ballesteros
Pages: 1-10 Published on: 01 March 2022
Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia
Ralf Bieker, Christian Lerchenmüller, Jürgen Wehmeyer, Hubert L. Serve, Rolf M. Mesters, Thomas Büchner, Wolfgang E. Berdel
Pages: 915-920 Published on: 01 July 2003
Anti-inflammatory effect of tricin isolated from Alopecurus aequalis Sobol. on the LPS-induced inflammatory response in RAW 264.7 cells
Byoung-Man Kang, Byoung-Kwan An, Won-Seok Jung, Ho-Kyung Jung, Jung-Hee Cho, Hyun-Woo Cho, Se Ji Jang, Young Beom Yun, Yong In Kuk
Pages: 1614-1620 Published on: 01 November 2016
Nutritional and prognostic value of bioelectrical phase angle as a potentially modifiable marker in acute myeloid leukemia
Tiantian Jiang, Yue Weng, Nan Zhang, Xiaoqiong Tang
Pages: 1-8 Published on: 01 March 2023
Gene expression profile related to prognosis of acute myeloid leukemia
Min Ha Park, Sun A. Cho, Kyung Hyun Yoo, Moon Hee Yang, Ji Young Ahn, Hyo Soo Lee, Kyoung-Eun Lee, Yeung-Chul Mun, Dae Ho Cho, Chu Myong Seong, Jong Hoon Park
Pages: 1395-1402 Published on: 01 December 2007
Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia
Sheng Luo, Fangfang Cai, Lei Jiang, Shenghui Zhang, Zhijian Shen, Lan Sun, Shenmeng Gao
Pages: 982-986 Published on: 01 March 2013
Open Access
Overexpression of ZEB2‑AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia
Xiaolan Shi, Jiao Li, Liang Ma, Lijun Wen, Qinrong Wang, Hong Yao, Changgeng Ruan, Depei Wu, Xinyou Zhang, Suning Chen
Pages: 4935-4947 Published on: 01 June 2019
Clinical efficacy of decitabine‑containing induction chemotherapy in de novo non‑elderly acute myeloid leukemia
Lu Zheng, Lifang Huang, Yan Hui, Liang Huang, Yi Li, Zhen Shang, Jia Wei, Zhiqiong Wang, Xia Mao, Yin Wang, Min Xiao, Donghua Zhang
Pages: 1521-1528 Published on: 01 June 2020
Open Access
Clinical significance of miR‑372 and miR‑495 in acute myeloid leukemia
Wei Zhang, Bo Wan, Bei Liu, Shiwen Wu, Li Zhao
Pages: 1938-1944 Published on: 01 August 2020
Open Access
Panel‑based next‑generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings
Hisashi Ishida, Akihiro Iguchi, Michinori Aoe, Ritsuo Nishiuchi, Takehiro Matsubara, Dai Keino, Masashi Sanada, Akira Shimada
Pages: 1-1 Published on: 01 November 2020
Open Access
Targeting cell death pathways in acute myeloid leukemia: Molecular mechanisms and clinical implications (Review)
Reaila Jianati, Haijing Chen, Xi Yang, Lixiang Yan, Yifei Guo, Chenyang Fan, Xiaogang Hao, Gengda Zhu, Zhexin Shi
Pages: 1-18 Published on: 01 December 2025
Open Access
Amyloid precursor protein has clinical and prognostic significance in AML1‑ETO‑positive acute myeloid leukemia
Guopan Yu, Changxin Yin, Ling Jiang, Dan Xu, Zhongxin Zheng, Zhixiang Wang, Chunli Wang, Hongsheng Zhou, Xuejie Jiang, Qifa Liu, Fanyi Meng
Pages: 917-925 Published on: 01 January 2018
Open Access
Single-cell genomic profiling of acute myeloid leukemia for clinical use: A pilot study
Benedict Yan, Yongli Hu, Kenneth H.K. Ban, Zenia Tiang, Christopher Ng, Joanne Lee, Wilson Tan, Lily Chiu, Tin Wee Tan, Elaine Seah, Chin Hin Ng, Wee‑Joo Chng, Roger Foo
Pages: 1625-1630 Published on: 01 March 2017
Clinical characteristics and laboratory analyses of acute myeloid leukemia with t(16;21)(p11;q22)
Zhifen Zhang, Jianwen Zou, Yuantang Li, Zhanfeng Liu, Rui Xu, Wenjun Tian, Zongchen Zhao, Hui Sun, Jingying Han, Jia Wang, Bingchang Zhang, Ying Ju
Pages: 2244-2248 Published on: 01 May 2015
Zoledronic acid overcomes adriamycin resistance in acute myeloid leukemia cells by promoting apoptosis
Rui‑Fang Fan, Yu‑Xin Chen, Zhi‑Gang Fang, Xiao‑Yan Guo, Ying Lu, Ling‑Ling Liu, Yi‑Chuan Xu, Xiang‑Fu Liu, Dong‑Jun Lin
Pages: 5660-5666 Published on: 01 December 2016
Novel tumor‑suppressor FOXN3 is downregulated in adult acute myeloid leukemia
Hang He, Jinjing Zhang, Yi Qu, Yue Wang, Yan Zhang, Xiaojing Yan, Yan Li, Rui Zhang
Pages: 1521-1529 Published on: 01 August 2019
Open Access
A clinical report on high‑dose cytarabine therapy for children with acute myeloid leukemia
Ziliang Wu, Zelin Wu, Yawei Zou, Jingming Guan, Shangzhi Wu, Dehui Chen
Pages: 1-6 Published on: 01 November 2022
A phase I study of CAR‑T bridging HSCT in patients with acute CD19<sup>+</sup> relapse/refractory B‑cell leukemia
Yongyong Ma, Shenghui Zhang, Hongliang Fang, Kang Yu, Songfu Jiang
Pages: 1-1 Published on: 01 October 2020
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Ana Espírito Santo, Sérgio Chacim, Isabel Ferreira, Luís Leite, Claudia Moreira, Dulcineia Pereira, Margarida Dantas Brito, Marta Nunes, Nelson Domingues, Isabel Oliveira, Ilídia Moreira, Angelo Martins, Luísa Viterbo, José Mário Mariz, Rui Medeiros
Pages: 262-268 Published on: 01 July 2016
Clinical significance of microRNA‑34b expression in pediatric acute leukemia
Lan Cao, Na Wang, Jian Pan, Shaoyan Hu, Wenli Zhao, Hailong He, Yi Wang, Guixiong Gu, Yihuan Chai
Pages: 2777-2784 Published on: 01 March 2016
Re-evaluation of various molecular targets located on CD34+CD38-Lin- leukemia stem cells and other cell subsets in pediatric acute myeloid leukemia
Yuping Cheng, Ming Jia, Yuanyuan Chen, Haizhao Zhao, Zebin Luo, Yongmin Tang
Pages: 891-897 Published on: 01 January 2016
Open Access
Expression and clinical significance of serum MMP‑7 and PTEN levels in patients with acute myeloid leukemia
Jiang Wu, Yu Song
Pages: 3447-3452 Published on: 01 March 2018
Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study
Bingjie Ding, Zhixiang Wang, Xuejie Jiang, Xiaodong Li, Chunli Wang, Qingxiu Zhong, Ling Jiang, Min Dai, Yu Zhang, Qi Wei, Fanyi Meng
Pages: 1139-1144 Published on: 01 September 2015
Open Access
Observation of clinical efficacy and toxic and side effects of pirarubicin combined with cytarabine on acute myeloid leukemia
Suqin Lv, Aihua Li, Haijuan Wu, Xiaoli Wang
Pages: 3411-3417 Published on: 01 March 2019
High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia
Ping Ma, Mengtao Xing, Lijie Han, Silin Gan, Jie Ma, Feifei Wu, Yumin Huang, Yanli Chen, Wenliang Tian, Chao An, Hui Sun, Ling Sun
Pages: 999-1009 Published on: 01 March 2020
Open Access
Clinical diagnosis of adult patients with acute megakaryocytic leukemia
Guangjie Zhao, Wanling Wu, Xiaoqin Wang, Jingwen Gu
Pages: 6988-6997 Published on: 01 December 2018
Expression of connexin 32 and connexin 43 in acute myeloid leukemia and their roles in proliferation
Sha Yi, Yan Chen, Lu Wen, Lijing Yang, Guohui Cui
Pages: 1003-1007 Published on: 01 November 2012
Open Access
Antiproliferative effects of L‑asparaginase in acute myeloid leukemia
Tingting Chen, Juan Zhang, Hui Zeng, Yue Zhang, Yong Zhang, Xiaohuan Zhou, Hebing Zhou
Pages: 2070-2078 Published on: 01 September 2020
In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase
Fankai Meng, Wen Zeng, Lifang Huang, Shuang Qin, Ningning Miao, Hanying Sun, Chunrui Li
Pages: 791-796 Published on: 01 March 2014
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial
Francesco Deodato, Savino Cilla, Gabriella Macchia, Luciana Caravatta, Samantha Mignogna, Mariangela Massaccesi, Vincenzo Picardi, Cinzia Digesu, Giuseppina Sallustio, Pierluigi Bonomo, Angelo Piermattei , Gabriella Ferrandina, Giovanni Scambia, Vincenzo Valentini, Numa Cellini, Alessio G Morganti
Pages: 1889-1896 Published on: 01 June 2013
Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells
Macario Martínez-Castillo, Nicolas Villegas-Sepúlveda, Marco A. Meraz-Rios, Araceli Hernández-Zavala, Jaime Berumen, Mathew A. Coleman, Lorena Orozco, Emilio J. Cordova
Pages: 6777-6783 Published on: 01 May 2018
SHIP1 is targeted by miR-155 in acute myeloid leukemia
Hua Xue, Luo-Ming Hua, Ming Guo, Jian-Min Luo
Pages: 2253-2259 Published on: 01 November 2014
Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells
Utz Krug, Amber Yasmeen, Carmela Beger, Nicole Bäumer, Martin Dugas, Wolfgang E. Berdel, Carsten Müller-Tidow
Pages: 129-136 Published on: 01 January 2009
CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia
Wenjian Guo, Aishu Dong, Chao Xing, Xiaoji Lin, Xiahui Pan, Ying Lin, Baoling Zhu, Muqing He, Rong‑Xing Yao
Pages: 825-830 Published on: 01 August 2014
Open Access
Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia
Haiguo Zhang, Chengfang Zhang, Rui Feng, Haixia Zhang, Min Gao, Ling Ye
Pages: 3981-3988 Published on: 01 October 2017
Circulating endothelial cells and their progenitors in acute myeloid leukemia
Asmaa Mohammed Zahran, Sanaa Shaker Aly, Hanan Ahmed Altayeb, Arwa Mohammed Ali
Pages: 1965-1970 Published on: 01 September 2016
Thiopurine methyltransferase activity in children with acute myeloid leukemia
Joanna Sobiak, Jolanta Skalska‑Sadowska, Maria Chrzanowska, Matylda Resztak, Sylwia Kołtan, Mariusz Wysocki, Jacek Wachowiak
Pages: 4699-4706 Published on: 01 October 2018
Granulocytic sarcoma of the breast in acute myeloid leukemia: Two case reports
Jianfei Fu, Jiansheng Luo
Pages: 145-147 Published on: 01 January 2014
Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies
H. B. Liu, D. Urbanavicius, P. Tan, A. Spencer, A. E. Dear
Pages: 1742-1748 Published on: 01 October 2014
Open Access
RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2‑deficient human acute myeloid leukemia
Yichuan Xu, Yansi Lin, Yuxuan Luo, Yanling Yang, Bing Long, Zhigang Fang, Lingling Liu, Jingwen Zhang, Xiangzhong Zhang
Pages: 1455-1466 Published on: 01 October 2020
Open Access
lncRNA‑CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia
Cunte Chen, Peipei Wang, Wenjian Mo, Yuping Zhang, Wei Zhou, Tingfen Deng, Ming Zhou, Xiaowei Chen, Shunqing Wang, Caixia Wang
Pages: 2203-2211 Published on: 01 September 2019
Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells
Rosa Di Liddo, Deborah Bridi, Michele Gottardi, Sergio De Angeli, Claudio Grandi, Alessia Tasso, Thomas Bertalot, Giovanni Martinelli, Filippo Gherlinzoni, Maria Teresa Conconi
Pages: 1659-1669 Published on: 01 April 2016
Comparison of spatial chromosomal organization between bone marrow and peripheral blood in acute myeloid leukemia
Xueli Tian, Yanfang Wang, Yu Liu, Jun Yin, Dieyan Chen, Xiaoyan Ke, Wanyun Ma
Pages: 4656-4662 Published on: 01 October 2018
Open Access
Elevated SPINK2 gene expression is a predictor of poor prognosis in acute myeloid leukemia
Cuiling Xue, Jialing Zhang, Guiju Zhang, Yuyan Xue, Guiyan Zhang, Xia Wu
Pages: 2877-2884 Published on: 01 September 2019
Sequence variations of mitochondrial DNA D‑loop region in patients with acute myeloid leukemia
Juan Zhou, Haimei Gou, Yuanxin Ye, Yi Zhou, Xiaojun Lu, Binwu Ying
Pages: 6269-6276 Published on: 01 November 2017
Open Access
Expression and role of fibroblast activation protein α in acute myeloid leukemia
Shuchong Mei, Yuan Zhang, Li Yu, Guoan Chen, Fuming Zi
Pages: 641-651 Published on: 01 February 2021
Open Access
Therapy‑related acute myeloid leukemia: A case series
Jie Yang, Baoan Chen
Pages: 1-5 Published on: 01 June 2022
shRNA-mediated RPS15A silencing inhibits U937 acute myeloid leukemia cell proliferation and enhances apoptosis
Guangyao Li, Li Zhang, Jizhu Liu, Taiwu Xiao, Guozhen Liu, Jingxia Wang, Ming Hou
Pages: 4400-4406 Published on: 01 May 2016
Open Access
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
Chie Oshita, Masako Takikawa, Akiko Kume, Haruo Miyata, Tadashi Ashizawa, Akira Iizuka, Yoshio Kiyohara, Shusuke Yoshikawa, Ryuji Tanosaki, Naoya Yamazaki, Akifumi Yamamoto, Kazutoh Takesako, Ken Yamaguchi, Yasuto Akiyama
Pages: 1131-1138 Published on: 01 October 2012
Open Access
WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines
Sara M. Ibrahim, Sherin Bakhashab, Asad M. Ilyas, Peter N. Pushparaj, Sajjad Karim, Jalaluddin A. Khan, Adel M. Abuzenadah, Adeel G. Chaudhary, Muhammed H. Al-Qahtani, Farid Ahmed
Pages: 3179-3188 Published on: 01 June 2019
Follow‑up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma
Robert Suriano, Shilpi Rajoria, Andrea L. George, Jan Geliebter, Raj K. Tiwari, Marc Wallack
Pages: 466-472 Published on: 01 May 2013
Open Access
PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia
Shiwen Wu, Wei Zhang, Dongqin Shen, Jianle Lu, Li Zhao
Pages: 6057-6065 Published on: 01 December 2019
Open Access
Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia
Guilan Li, Yang Gao, Kun Li, Anqi Lin, Zujun Jiang
Pages: 1824-1834 Published on: 01 August 2020
MicroRNA‑425 upregulation indicates better prognosis in younger acute myeloid leukemia patients undergoing chemotherapy
Jilei Zhang, Jinlong Shi, Gaoqi Zhang, Xinpei Zhang, Xinrui Yang, Siyuan Yang, Jing Wang, Kai Hu, Xiaoyan Ke, Lin Fu
Pages: 5793-5802 Published on: 01 June 2019
Open Access
Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia
Ioannis Panagopoulos, Ludmila Gorunova, Bernward Zeller, Anne Tierens, Sverre Heim
Pages: 2587-2592 Published on: 01 December 2013
Atypical breast adenosquamous carcinoma following acute myeloid leukemia in a middle-aged woman: A case report
Seyed Mehdi Hashemi, Shokoufeh Mahmoudi Shan, Mahdi Jahantigh, Abolghasem Allahyari
Pages: 271-275 Published on: 01 February 2017
A novel melting curve‑based method for detecting c‑kit mutations in acute myeloid leukemia
Quanyi Lu, Xiao Huang, Huaying Chen, Xiaomin Zhao
Pages: 99-104 Published on: 01 July 2014
Open Access
Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients
Yan-Fang Tao, Shao-Yan Hu, Jun Lu, Lan Cao, Wen-Li Zhao, Pei-Fang Xiao, Li-Xiao Xu, Zhi-Heng Li, Na-Na Wang, Xiao-Juan Du, Li-Chao Sun, He Zhao, Fang Fang, Guang-Hao Su, Yan-Hong Li, Yi-Ping Li, Yun-Yun Xu, Jian Ni, Jian Wang, Xing Feng, Jian Pan
Pages: 1505-1515 Published on: 01 December 2014
Gene coexpression network analysis revealed biomarkers correlated with blast cells and survival in acute myeloid leukemia
Yuming Pan, Qiaoxia Zhang, Xiaopeng Deng, Na An, Xin Du, Jiajun Liu
Pages: 475-484 Published on: 01 May 2020
Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia
Ana Espirito Santo, Sergio Chacim, Isabel Ferreira, Luis Leite, Claudia Moreira, Dulcineia Pereira, Margarida Dantas, Marta Nunes, Luisa Viterbo, Ilidia Moreira, Angelo Martins, Isabel Oliveira, Nelson Domingues, Jose Mariz, Rui Medeiros
Pages: 384-388 Published on: 01 March 2017
Open Access
Integrated analysis and validation reveal CYTH4 as a potential prognostic biomarker in acute myeloid leukemia
Hong Wang, Yishu Xiao, Wei Zhou, Yonghui Li
Pages: 1-14 Published on: 01 March 2024
Open Access
Novel AXL‑targeted agents overcome FLT3 inhibitor resistance in FLT3‑ITD+ acute myeloid leukemia cells
Yi Liu, Jing Wei, Jiaxin Liu, Weina Ma, Yanting Duan, Daihong Liu
Pages: 1-10 Published on: 01 May 2021
Open Access
Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression
Jiahui Li, Bin Tang, Ying Miao, Guihong Li, Zhenliang Sun
Pages: 1-11 Published on: 01 December 2023
Open Access
CD155 and CD112 as possible therapeutic targets of <em>FLT3</em> inhibitors for acute myeloid leukemia
Yuta Kaito, Mitsuhito Hirano, Muneyoshi Futami, Masanori Nojima, Hideto Tamura, Arinobu Tojo, Yoichi Imai
Pages: 1-12 Published on: 01 February 2022
Open Access
MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia
Kun Wu, Yuntao Li, Bo Nie, Chong Guo, Xiaobo Ma, Linyan Li, Shenju Cheng, Yanhong Li, Shan Luo, Yun Zeng, Jian Yu, Mingxia Shi
Pages: 1-17 Published on: 01 November 2024
Hsp27: A novel therapeutic target for pediatric M4/M5 acute myeloid leukemia
Liangchun Yang, Lizhi Cao, Minghua Yang, Daolin Tang, Rui Kang, Xie Min, Shan Zhu, Yan Yu
Pages: 1459-1466 Published on: 01 April 2013
Open Access
New prognostic factors and scoring system for patients with acute myeloid leukemia
Ye Kuang, Yang Wang, Xianghong Cao, Chuanmei Peng, Hui Gao
Pages: 1-15 Published on: 01 December 2021
Open Access
Acute myeloid leukemia with plasmacytoid dendritic cell proliferation: A case report and literature review
Zhixin Pei, Yi Zhang, Han Xu, Pei Pei, Zhengyang Zhang, Hongxia Wang, Bei Zhang, Junjun Bai, Yingxin Zhao, Jingjing Gu, Zhiyu Fang, Miaomiao Liu, Qinglin Song
Pages: 1-10 Published on: 01 October 2025
Open Access
A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy
Eriko Takatori, Tadahiro Shoji, Yuki Miura, Miyuki Nagao, Anna Takada, Takayuki Nagasawa, Hideo Omi, Masahiro Kagabu, Tatsuya Honda, Toru Sugiyama
Pages: 281-286 Published on: 01 March 2015
Open Access
MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia
Laixi Bi, Lan Sun, Zhenlin Jin, Shenghui Zhang, Zhijian Shen
Pages: 5611-5619 Published on: 01 April 2018
Polymorphism analysis of CYP3A5 in myeloid leukemia
Ta-Chih Liu, Sheng-Fung Lin, Tyen-Po Chen, Jan-Gowth Chang
Pages: 327-329 Published on: 01 March 2002
Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia
Flaviana R. Reis, Flavia C. Vasconcelos, Débora L. Pereira, Arthur Moellman-Coelho, Karina L. Silva, Raquel C. Maia
Pages: 471-478 Published on: 01 August 2011
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia
Carmelo Gurnari, Paola Panetta, Emiliano Fabiani, Anna Maria Nardone, Diana Postorivo, Giulia Falconi, Luca Franceschini, Manuela Rizzo, Vito Mario Rapisarda, Eleonora De Bellis, Francesco Lo‑Coco, Maria Teresa Voso
Pages: 463-465 Published on: 01 March 2018
Open Access
Evaluation of azacitidine in patients with transplant‑ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia‑related changes in a Japanese clinical setting
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Ryo Saito, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Pages: 1317-1321 Published on: 01 February 2020
Open Access
Azacitidine plus venetoclax for maintenance treatment in intermediate‑to‑low‑risk acute myeloid leukemia: A comparative analysis of clinical outcomes in an observational cohort
Danyang Zhang, Xiaomin Dong, Yue Zhang, Xiaolei Chen, Jiaoyan Qu, Tingting Chen, Hebing Zhou
Pages: 1-8 Published on: 01 June 2025
Open Access
Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion
Ioannis Panagopoulos, Ludmila Gorunova, Petter Brandal, Margaret Garnes, Anne Tierens, Sverre Heim
Pages: 1549-1552 Published on: 01 October 2013
Chronic myeloid leukemia treated with busulfan
P Foa, A Iurlo, S Ribera, I DaMilano, S Caldiera, M Fornier, F Bertoni, A Maiolo
Pages: 1067-1069 Published on: 01 November 1996
Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype
Madeleine Gross, Hasmik Mkrtchyan, Melanie Glaser, Hans Jörg Fricke, Klaus Höffken, Anita Heller, Anja Weise, Thomas Liehr
Pages: 417-423 Published on: 01 February 2009
Open Access
Mechanisms of T‑cell metabolic reprogramming in the microenvironment of acute myeloid leukemia and its therapeutic potential (Review)
Yanhong Luo, Jie Luo, Min Yang, Xueya Zhao
Pages: 1-11 Published on: 01 October 2025
Core binding factor acute myeloid leukemia: Advances in the heterogeneity of KIT, FLT3, and RAS mutations (Review)
Xi Quan, Jianchuan Deng
Pages: 95-100 Published on: 01 August 2020
Open Access
Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer
Kiyotaka Okuno, Fumiaki Sugiura, Jin-ichi Hida, Tadao Tokoro, Eizaburo Ishimaru, Yasushi Sukegawa, Kazuki Ueda
Pages: 73-79 Published on: 01 January 2011
Open Access
Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer
Yoshie Higashihara, Junko Kato, Akihito Nagahara, Kentaro Izumi, Masae Konishi, Tomohiro Kodani, Nobuko Serizawa, Taro Osada, Sumio Watanabe
Pages: 662-668 Published on: 01 March 2014
Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of acute myeloid leukemia cells
Na Li, Xiuhong Jia, Jianyong Wang, Youjie Li, Shuyang Xie
Pages: 6861-6866 Published on: 01 November 2015
Open Access
Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia
Zhenqing Tan, Kaibo Zhu, Yafei Yin, Zimian Luo
Pages: 1-1 Published on: 01 February 2021
Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study
Maki Hagihara, Noriyoshi Iriyama, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki
Pages: 2976-2982 Published on: 01 November 2016
Open Access
Philadelphia chromosome with acute myeloid leukemia and concurrent large B cell lymphoma of different origins: A case report
Yang Dai, Xiao Shuai, Pu Kuang, Lin Wang, Ting Liu, Ting Niu
Pages: 1189-1193 Published on: 01 March 2017
Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors
Hui Cao, Yizhi Cheng, Liangshun You, Jiejing Qian, Wenbin Qian
Pages: 1838-1844 Published on: 01 June 2013
Open Access
Identification and validation of a novel prognostic model based on anoikis‑related genes in acute myeloid leukemia
Yundong Chen, Wencong Luo, Mingyue Hu, Xiaoyu Yao, Jishi Wang, Yi Huang
Pages: 1-12 Published on: 01 January 2025
Open Access
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low‑dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report
Keisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, Shinya Ishida, Toshikage Nagao, Masahide Yamamoto, Osamu Miura
Pages: 97-102 Published on: 01 July 2017
Overexpression of long non‑coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia
Shenghao Wu, Cuiping Zheng, Songyan Chen, Xiaoping Cai, Yuejian Shi, Bijing Lin, Yuemiao Chen
Pages: 2410-2414 Published on: 01 October 2015
Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia
Hao Wu, Peng Li, Na Shao, Jingjing Ma, Min Ji, Xiulian Sun, Daoxin Ma, Chunyan Ji
Pages: 1119-1123 Published on: 01 May 2012
Comparative investigation of the anti-emetic effects of granisetron and palonosetron during the treatment of acute myeloid leukemia
Aki Matsumaru, Yutaka Tsutsumi, Shinichi Ito
Pages: 629-632 Published on: 01 October 2017
Open Access
Meta‑analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia
Yuqin Xie, Xueqin Wei, Weiwei Wang, Changsheng Liao, Pengfei Han, Yanhui Yu
Pages: 1-9 Published on: 01 April 2024
Induction of molecular remission by donor peripheral blood leukocyte therapy in patients relapsing with extramedullary blastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation.
A Bashey, S Shepherd, W Frankel, J Wang-Rodriguez, T Cahill, M Chamberlain, J R Mason, A D Ho, R E Corringham
Pages: 281-286 Published on: 01 January 1998
Open Access
Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
Junichiro Kawamura, Fumiaki Sugiura, Yasushi Sukegawa, Yasumasa Yoshioka, Jin‑Ichi Hida, Shoichi Hazama, Kiyotaka Okuno
Pages: 4241-4247 Published on: 01 April 2018
Seven-day capecitabine plus docetaxel and oxaliplatin regimen for the treatment of advanced gastric cancer: A phase-I clinical trial
Rong Liang, Yan Lin, Yongqiang Li, Qian Li, Chunling Yuan, Xiaoli Liao, Sina Liao, Jinyan Zhang, Zhihui Liu
Pages: 622-626 Published on: 01 April 2017
A multi-center, late phase II clinical trial of Genexol® (paclitaxel) and cisplatin for patients with advanced gastric cancer
Sook Ryun Park, Do-Youn Oh, Dong-Wan Kim, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim, Won Ki Kang, Heung-Tae Kim, Seock-Ah Im, Jae-Hong Suh, Hark-Kyun Kim, Hoon-Kyo Kim
Pages: 1059-1064 Published on: 01 November 2004
Open Access
NADH dehydrogenase subunit 1/4/5 promotes survival of acute myeloid leukemia by mediating specific oxidative phosphorylation
Ye Kuang, Chuanmei Peng, Yulin Dong, Jia Wang, Fanbin Kong, Xiaoqing Yang, Yang Wang, Hui Gao
Pages: 1-10 Published on: 01 June 2022
Open Access
Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing
Guopan Yu, Changxin Yin, Fuqun Wu, Ling Jiang, Zhongxin Zheng, Dan Xu, Jiaheng Zhou, Xuejie Jiang, Qifa Liu, Fanyi Meng
Pages: 2333-2344 Published on: 01 December 2019
